Anti-Hyperglycemic Medication Adherence and Health Services Utilization in People with Diabetes: A Longitudinal Study of Alberta’s Tomorrow Project

References

• Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. 2014;48(5):562–570. doi:10.1177/1060028014526362
   PubMed Web of Science ®Google Scholar
• Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27(12):2800–2805. doi:10.2337/diacare.27.12.2800
   PubMed Web of Science ®Google Scholar
• Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–1841. doi:10.1001/archinte.166.17.1836
   PubMed Web of Science ®Google Scholar
• Simpson SH, Lin M, Eurich DT. Medication adherence affects risk of new diabetes complications: a cohort study. Ann Pharmacother. 2016;50(9):741–746. doi:10.1177/1060028016653609
   PubMed Web of Science ®Google Scholar
• Currie CJ, Peyrot M, Morgan CL, et al. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care. 2012;35(6):1279–1284. doi:10.2337/dc11-1277
   PubMed Web of Science ®Google Scholar
• Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27(9):2149–2153. doi:10.2337/diacare.27.9.2149
   PubMed Web of Science ®Google Scholar
• Nasseh KFS, Visaria J, Vlahiotis A, Tian Y. Cost of medication nonadherence associated with diabetes, hypertension, and dyslipidemia. Am J Pharm Benefits. 2012;4(2):e41–e47.
   Google Scholar
• Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan,TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. 2011;30(1):91–99. doi:10.1377/hlthaff.2009.1087
   PubMed Web of Science ®Google Scholar
• Hajos TR, Polonsky WH, Pouwer F, Gonder-Frederick L, Snoek FJ. Toward defining a cutoff score for elevated fear of hypoglycemia on the hypoglycemia fear survey worry subscale in patients with type 2 diabetes. Diabetes Care. 2014;37(1):102–108. doi:10.2337/dc13-0971
   PubMed Web of Science ®Google Scholar
• Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabetic Med. 2015;32(6):725–737. doi:10.1111/dme.12651
   PubMed Web of Science ®Google Scholar
• Iglay K, Cartier SE, Rosen VM, et al. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes. Curr Med Res Opin. 2015;31(7):1283–1296. doi:10.1185/03007995.2015.1053048
   PubMed Web of Science ®Google Scholar
• Chen CC, Cheng SH. Continuity of care and changes in medication adherence among patients with newly diagnosed diabetes. Am J Manag Care. 2016;22(2):136–142.
   PubMed Web of Science ®Google Scholar
• Campos LF, Glickman ME, Hunter KB. Measuring effects of medication adherence on time-varying health outcomes using Bayesian dynamic linear models. Biostatistics. 2019;22(3):662–683.
   Web of Science ®Google Scholar
• Donnelly LA, Doney AS, Morris AD, Palmer CN, Donnan PT. Long-term adherence to statin treatment in diabetes. Diabetic Med. 2008;25(7):850–855. doi:10.1111/j.1464-5491.2008.02476.x
   PubMed Web of Science ®Google Scholar
• Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther. 2006;31(5):409–419. doi:10.1111/j.1365-2710.2006.00759.x
   PubMed Web of Science ®Google Scholar
• Hunt KJ, Gebregziabher M, Lynch CP, Echols C, Mauldin PD, Egede LE. Impact of diabetes control on mortality by race in a national cohort of veterans. Ann Epidemiol. 2013;23(2):74–79. doi:10.1016/j.annepidem.2012.11.002
   PubMed Web of Science ®Google Scholar
• Yu AP, Yu YF, Nichol MB. Estimating the effect of medication adherence on health outcomes among patients with type 2 diabetes–an application of marginal structural models. Value Health. 2010;13(8):1038–1045. doi:10.1111/j.1524-4733.2010.00787.x
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–349. doi:10.1016/j.jclinepi.2007.11.008
   PubMed Web of Science ®Google Scholar
• Csizmadi I, Kahle L, Ullman R, et al. Adaptation and evaluation of the National Cancer Institute’s Diet History Questionnaire and nutrient database for Canadian populations. Public Health Nutr. 2007;10(1):88–96. doi:10.1017/S1368980007184287
   PubMed Web of Science ®Google Scholar
• Friedenreich CM, Courneya KS, Neilson HK, et al. Reliability and validity of the past year total physical activity questionnaire. Am J Epidemiol. 2006;163(10):959–970. doi:10.1093/aje/kwj112
   PubMed Web of Science ®Google Scholar
• Public Health Agency of Canada. Report from the national diabetes surveillance system: diabetes in Canada; 2009.
   Google Scholar
• Zongo A, Gregoire JP, Moisan J, Guenette L. Measuring adherence to oral antidiabetic multi-drug treatment: comparative validity of prescription claims-based adherence measures against hospitalization. Res Social Adm Pharm. 2019;15(6):738–743. doi:10.1016/j.sapharm.2018.09.005
   PubMed Web of Science ®Google Scholar
• McGovern A, Tippu Z, Hinton W, Munro N, Whyte M, de Lusignan S. Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol. BMJ Open. 2016;6(2):e010469. doi:10.1136/bmjopen-2015-010469
   PubMed Web of Science ®Google Scholar
• Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care. 2009;15(7):457–464.
   PubMed Web of Science ®Google Scholar
• Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009;25(9):2303–2310. doi:10.1185/03007990903126833
   PubMed Web of Science ®Google Scholar
• Knight JC, Mathews M, Aubrey-Bassler K. Relation between family physician retention and avoidable hospital admission in Newfoundland and Labrador: a population-based cross-sectional study. CMAJ Open. 2017;5(4):E746–E752. doi:10.9778/cmajo.20170007
   PubMedGoogle Scholar
• Armitage P, Matthews J. Statistical Methods in Medical Research. John Wiley and Sons; 2008.
   Google Scholar
• Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5Suppl Guidelines):S265–280. doi:10.1046/j.1532-5415.51.5s.1.x
   PubMedGoogle Scholar
• Garriguet D. Diet quality in Canada. Health Rep. 2009;20(3):41–52.
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27. doi:10.1097/00005650-199801000-00004
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Miller ME; Action to Control Cardiovascular Risk in Diabetes Study G. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–2559.
   PubMed Web of Science ®Google Scholar
• Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–530. doi:10.1097/01.mlr.0000163641.86870.af
   PubMed Web of Science ®Google Scholar
• Juarez DT, Tan C, Davis J, Mau M. Factors affecting sustained medication adherence and its impact on health care utilization in patients with diabetes. J Pharm Health Serv Res. 2013;4(2):89–94. doi:10.1111/jphs.12016
   PubMedGoogle Scholar
• Basak R, Bentley JP, McCaffrey DJ 3rd, West-Strum D, Przybyla SM, Banahan BF 3rd. Comparing algorithms for composite measures of intra-disease multiple medication adherence: the case of diabetes. Res Social Adm Pharm. 2019;15(9):1160–1167. doi:10.1016/j.sapharm.2018.09.024
   PubMed Web of Science ®Google Scholar
• Karlsson SA, Hero C, Svensson AM, et al. Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study. BMJ Open. 2018;8(3):e020309. doi:10.1136/bmjopen-2017-020309
   PubMed Web of Science ®Google Scholar
• Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care. 2010;33(2):442–449. doi:10.2337/dc09-0749
   PubMed Web of Science ®Google Scholar
• Zanders MMJ, Haak HR, van Herk-Sukel MPP, van de Poll-Franse LV, Johnson JA. Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes. Diabetologia. 2015;58(5):951–960. doi:10.1007/s00125-015-3497-8
   PubMed Web of Science ®Google Scholar
• Okemah J, Peng J, Quinones M. Addressing clinical inertia in Type 2 diabetes mellitus: a review. Adv Ther. 2018;35(11):1735–1745. doi:10.1007/s12325-018-0819-5
   PubMed Web of Science ®Google Scholar
• Khunti K, Millar-Jones D. Clinical inertia to insulin initiation and intensification in the UK: a focused literature review. Prim Care Diabetes. 2017;11(1):3–12. doi:10.1016/j.pcd.2016.09.003
   PubMed Web of Science ®Google Scholar
• Eskin M, Simpson SH, Eurich DT. Evaluation of healthy user effects with metformin and other oral antihyperglycemia medication users in adult patients with Type 2 diabetes. Can J Diabetes. 2019;43(5):322–328. doi:10.1016/j.jcjd.2018.12.001
   PubMed Web of Science ®Google Scholar
• Austin PC. Generating survival times to simulate Cox proportional hazards models with time-varying covariates. Stat Med. 2012;31(29):3946–3958. doi:10.1002/sim.5452
   PubMed Web of Science ®Google Scholar
• Ye M, Robson PJ, Eurich DT, Vena JE, Xu JY, Johnson JA. Cohort profile: alberta’s tomorrow project. Int J Epidemiol. 2016;46(4):1097–8l.
   Web of Science ®Google Scholar
• Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047. doi:10.1155/2015/217047
   PubMed Web of Science ®Google Scholar